Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.

Michael Petras

Sotera Health Company

Nordion

Sterigenics

Nelson Labs

Sotera Health brings together Sterigenics, Nelson Labs and Nordion, each of which are established, highly reputable players in the global health arena. Working as a team, Sotera Health and its companies have one common goal: Safeguarding Global Health®. With these three companies operating together, Sotera Health, formerly Sterigenics International, leverages more than 500 combined years of scientific expertise to ensure safety across the medical device, pharma, tissue and food industries. With over 2,800 employees globally, including more than 350 scientists, the company operates 63 facilities worldwide across 13 countries. Our purpose is bigger than the products and services we provide. We ensure that health care around the world is consistently and reliably safe every day. Our purpose, our conduct, and our values are at the heart of our commitment to employee safety, environmental responsibility, and sustainability principles.The Sotera Health name is new, but our track record for reliability and safety in global health is well established. Formed in 2017 as the parent company for Nelson Labs, Nordion and Sterigenics, Sotera Health is the leader in protecting global health thanks to the longstanding reputation for quality across each of its companies.  In aggregate, Sotera Health has over 185 years of combined industry leadership. Sterigenics has provided safe sterilization services since the 1930s. Nordion has established expertise in gamma technologies and medical isotopes since 1946. Nelson Labs has provided expert lab testing since 1985. Our most recent addition to the Sotera Health family, Toxikon Europe, has established a leading extractables and leachables testing platform since 1990. An impressive history that points to an even brighter future.

Metric
Company Name	Sotera Health Company
Symbol	SHC
MSH ID	COM:SOTERAHEALTH
Market	STOCKS
Sector	Healthcare
Industry	Medical - Diagnostics & Research
Country	US
Stage
Employee Count	3K
Website	soterahealth.com
LinkedIn	sotera-health-llc
Founders

Metric
Market Cap	3.31B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue	1.05B
Revenue (LTM)
Revenue (NTM)
Gross Profit	513.36M
EBITDA	516.81M
Operating Income	356.48M
Net Income	51.38M
EPS	0.18
Diluted EPS	0.18
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.54
Operating Profit Margin	0.31
EBITDA Margin	0.49
Net Profit Margin	0.05
Return on Equity	0.13
Return on Assets	0.02
Return on Capital Employed	0.12

COM:SOTERAHEALTH

Sotera Health

Last Close

12.41

22/11 21:00

Market Cap

3.31B

Beta: -

Volume Today

4.17M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-13.87
P/B Ratio	11.28
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	4.36
EV Multiple	5.56

Metric
Days Sales Outstanding	43.62
Days Payables Outstanding	46.15
Days Inventory Outstanding	41.81
Operating Cycle	99.95
Cash Conversion Cycle	51.52
Asset Turnover	0.36

Metric
Operating Cash Flow	-173.38M
Free Cash Flow	-388.35M
Cash Flow to Debt	0.09
Operating Cash Flow/Sales	0.18
Free Cash Flow Yield	-0.09

Metric
Cash & Equivalents	301.65M
Accounts Receivable	-21.72M
Inventory	51.98M
Goodwill	1.11B
Debt to Capitalization	0.84
Debt to Assets	0.74
Current Ratio	2.59
Quick Ratio	2.84

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.03
R&D to Revenue
SG&A to Revenue